Commercial
Advanced Search
MPDocType
  
Title
  
MPPolicyNumber
  
MPNotificationIssuedDate
  
MPEffectiveDate
  
MPReissuedDate
  
MPArchiveNotifEffDate
  
MPSALogCreatedOn
  
MPPolicyChangeTypeslt
  
MPRevisionDate
  
MPSiteActivityRemovedDate
  
News & Announcements1/01/2025 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products1/3/2025
New PoliciesMedical Nutrition Therapy (MNT)/Nutrition Counseling10.00.0412/2/2024 2:00 PM1/1/20251/1/2025This is a New Policy.
New PoliciesDrugs, Biologics, or Gene Therapies with an Accelerated Approval08.02.3512/2/2024 2:00 PM1/1/20251/2/2025This is a New Policy.
New PoliciesIntravenous (IV) Iron Preparations08.02.291/1/20251/15/2025This is a New Policy.1/15/2025
New PoliciesIntravenous (IV) Iron Preparations08.02.291/1/20251/15/2025This is a New Policy.
Updated PoliciesMonoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer Disease08.01.93e12/2/2024 3:00 PM1/1/20251/1/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;General Description, Guidelines, or Informational Update
Updated PolicieseviCore Lab Management (Independence)06.02.52ai12/2/2024 5:00 PM1/1/20251/1/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesFetal Surgery11.00.03m12/3/2024 3:00 PM1/1/20251/1/2025Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesPreventive Care Services00.06.02at1/1/20251/1/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding
Updated PoliciesExon Skipping Drugs for Duchenne Muscular Dystrophy (DMD) (Eteplirsen (Exondys 51), Golodirsen (Vyondys 53), Viltolarsen (Viltepso)), Casimersen (Amondys 45)08.01.34d12/2/2024 3:00 PM1/1/20251/1/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria
Updated PoliciesEndovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions11.02.17i1/1/20251/2/2025Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesAmbulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring07.02.21q1/1/20251/2/2025Medical Coding
Updated PoliciesOvarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome11.06.07e1/1/20251/2/2025General Description, Guidelines, or Informational Update
Updated PoliciesTofersen (Qalsody®)08.02.06b12/2/2024 9:00 AM1/1/20251/2/2025Coverage and/or Reimbursement Position
Updated PoliciesAtezolizumab (Tecentriq®) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza TM)08.01.69d1/1/20251/2/2025Medical Necessity Criteria
Updated PoliciesAsparaginase Erwinia Chrysanthemi (recombinant)-rywn (Rylaze®)08.01.35i1/1/20251/2/2025Medical Necessity Criteria
Updated PoliciesTotal Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN) / Intraperitoneal Parenteral Nutrition (IPN)08.00.17k12/3/2024 9:00 AM1/1/20251/2/2025Medical Necessity Criteria
Updated PoliciesSkilled Nursing Facility (SNF): Skilled and Subacute Levels of Care02.03.00a1/6/20251/6/2025General Description, Guidelines, or Informational Update
Updated PoliciesTeprotumumab-trbw (Tepezza®)08.00.41b1/6/20251/6/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesOmalizumab (Xolair®)08.00.55l1/6/20251/6/2025Coverage and/or Reimbursement Position
Updated PoliciesVagus Nerve Stimulation (VNS)11.15.16w1/6/20251/6/2025Medical Coding
Updated PoliciesHome Health Care Services02.01.01g1/6/20251/6/2025General Description, Guidelines, or Informational Update
Updated PoliciesCervical Traction Devices for In-home Use05.00.61h1/6/20251/6/2025General Description, Guidelines, or Informational Update
Updated PoliciesHigh-Frequency Chest Wall Oscillation Devices05.00.14q10/17/20241/6/2025Medical Coding
Updated PoliciesStem-Cell Therapy/Platelet-Rich Plasma for Orthopedic Applications and ​Platelet-Rich Plasma/Platelet-Derived Growth Factor for Wound Healing and Other Miscellaneous Non-Orthopedic Conditions07.07.09j1/6/20251/6/2025Coverage and/or Reimbursement Position;General Description, Guidelines, or Informational Update
Updated PoliciesIntravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) Inhibitors08.00.74x10/8/2024 9:00 AM1/1/20251/6/2025Medical Necessity Criteria1/6/2025
Updated PoliciesVagus Nerve Stimulation (VNS)11.15.16w1/6/20251/7/2025Medical Coding1/7/2025
Updated PoliciesVagus Nerve Stimulation (VNS)11.15.16w1/6/20251/10/2025Medical Coding
Updated PoliciesTreatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence11.02.01t12/13/2024 11:00 AM1/13/20251/13/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesModifier 50: Bilateral Procedure03.00.05z12/13/2024 2:00 PM1/13/20251/13/2025Medical Coding
Updated PoliciesModifier 62: Two Surgeons00.10.11ab12/13/2024 2:00 PM1/13/20251/13/2025Medical Coding
Updated PoliciesLuspatercept–aamt (Reblozyl®)08.00.10d10/22/2024 11:00 AM1/17/20251/17/2025Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update1/17/2025
Reissue PoliciesTherapies for Spinal Muscular Atrophy Nusinersen (Spinraza®) and Onasemnogene abeparvovec-xioi (Zolgensma®)08.01.36e7/1/202010/2/20241/3/2025
Reissue PoliciesPeroral Endoscopic Myotomy (POEM) Procedures11.03.172/19/20249/18/20241/3/2025
Coding UpdateImmune Globulin Intravenous (IVIG), Subcutaneous (SCIG)08.00.13ak1/1/20251/2/2025
Coding UpdateFilgrastim (Neupogen®) and Related Biosimilars, and tbo-filgrastim (Granix®)08.01.73g1/1/20251/2/2025
Coding UpdateSurgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)11.17.06s1/1/20251/3/2025
Coding UpdateGenetic Testing (Independence Administrators)06.02.35ao7/1/20241/6/2025
Coding UpdateNoninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease06.02.56i7/1/20241/6/2025
Coding UpdatePrescription Digital Therapeutics and Mobile-Based Health Management Applications12.00.05d1/1/20251/6/2025
Coding UpdatePercutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (Independence)11.02.27j1/1/20251/14/20251/14/2025
Coding UpdatePercutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (Independence)11.02.27j1/1/20251/15/2025
Coding UpdateAcupuncture12.00.01i1/1/20251/15/2025
Connect with Us

2025 Independence Blue Cross

Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.